True Wealth Design’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAM
True Wealth Design's RNAM Position: Q1 2026 in Review
True Wealth Design sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 15 shares — an estimated $1.08K sold.
True Wealth Design first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $1.08K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- True Wealth Design reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- True Wealth Design sold 15 Avidity Biosciences shares in Q1 2026, an estimated $1.08K.
- True Wealth Design first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
- True Wealth Design's Avidity Biosciences position peaked at $1.08K in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on True Wealth Design's 13F filing for Q1 2026, filed 13 Apr 2026.